Kyle G. Potts
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.
Journal: Nature cancer
Published: April 29, 2026
VSV∆M51 drives CD8+ T cell-mediated tumour regression through infection of both cancer and non-cancer cells.
Journal: Nature communications
Published: October 11, 2023
High-titer manufacturing of SARS-CoV-2 Spike-pseudotyped VSV in stirred-tank bioreactors.
Journal: Molecular therapy. Methods & clinical development
Published: April 26, 2023
A B1a-natural IgG-neutrophil axis is impaired in viral- and steroid-associated aspergillosis.
Journal: Science translational medicine
Published: December 08, 2022
Stroke-associated intergenic variants modulate a human FOXF2 transcriptional enhancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 22, 2022
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 18, 2022
Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma.
Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma.
Journal: Cancer letters
Published: September 10, 2021
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 30, 2021
Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro.
Journal: International journal of molecular sciences
Published: March 10, 2021
Last Updated: 09/26/2026